Canada’s regulatory approach to drugs for rare diseases: orphan drugs (French, HTML)

Canada’s regulatory approach to drugs for rare diseases: orphan drugs: French HTML file. From Health Canada, updated Dec 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-12-02

Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.

Access original file

Data overview

Formats
HTML
File languages
French
Available actions
Access original file

Official sources and licences

Related open data